Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy

NCT01153672 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Male Breast Cancer
Recurrent Breast Cancer
Stage IV Breast Cancer

Interventions

DRUG: vorinostat
OTHER: laboratory biomarker analysis
PROCEDURE: biopsy
RADIATION: F-18 16 alpha-fluoroestradiol
PROCEDURE: positron emission tomography
DRUG: anastrozole
DRUG: letrozole
DRUG: exemestane
GENETIC: gene expression analysis

Sponsor

University of Washington

Collaborators

[object Object]